In the screening of asymptomatic patients with PC, the clinical role of serologic markers, which includes CA19-9, carcinoembryonic antigen (CEA), osteopontin (OPN), macrophage inhibitory cytokine 1 (MIC-1), and S100A6, has been limited. Here, SPP1 is linked to pachyonychia congenita.